KMPharmaceutical Co Ltd
KOSDAQ:225430
KMPharmaceutical Co Ltd
Total Receivables
KMPharmaceutical Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KMPharmaceutical Co Ltd
KOSDAQ:225430
|
Total Receivables
₩1.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Total Receivables
₩328.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
Amorepacific Group
KRX:002790
|
Total Receivables
₩355.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-2%
|
|
|
Cosmax Inc
KRX:192820
|
Total Receivables
₩455.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
|
LG H&H Co Ltd
KRX:051900
|
Total Receivables
₩744B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Total Receivables
₩366B
|
CAGR 3-Years
8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
KMPharmaceutical Co Ltd
Glance View
KMPHARMACEUTICAL Co., Ltd. engages in the development and sale of oral health products. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2015-10-08. Oral hygiene products include toothpaste, toothbrush and goggles. Cosmetic products consist of shampoo, body wash, sun cream, moisturizing cream, as well as lip balm and others. The firm distributes its products within domestic market and to overseas markets including North America, South America, Europe, China, Malaysia, Singapore, Vietnam and Australia.
See Also
What is KMPharmaceutical Co Ltd's Total Receivables?
Total Receivables
1.7B
KRW
Based on the financial report for Sep 30, 2025, KMPharmaceutical Co Ltd's Total Receivables amounts to 1.7B KRW.
What is KMPharmaceutical Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
-7%
Over the last year, the Total Receivables growth was -23%. The average annual Total Receivables growth rates for KMPharmaceutical Co Ltd have been -17% over the past three years , -7% over the past five years .
